Indeed, simultaneous ANGPT-2 and VEGFR2 inhibition impairs tumor growth, prolong vessel normalization and blocks macrophage recruitment improving survival of glioma bearing mice [151, 152]. The gene discussed is KDR; the disease is glioma.